WINT logo

Windtree Therapeutics (WINT) Current Liabilities

Annual Current Liabilities

$4.00 M
+$1.54 M+62.64%

31 December 2023

WINT Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$8.78 M
+$3.79 M+76.03%

30 June 2024

WINT Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

WINT Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+62.6%+136.6%
3 y3 years-34.8%+70.6%
5 y5 years-80.6%-46.1%

WINT Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-34.8%+62.6%at high+257.1%
5 y5 years-80.6%+62.6%-46.1%+257.1%
alltimeall time-80.6%+1232.0%-70.2%+2825.0%

Windtree Therapeutics Current Liabilities History

DateAnnualQuarterly
June 2024
-
$8.78 M(+76.0%)
Mar 2024
-
$4.99 M(+24.7%)
Dec 2023
$4.00 M(+62.6%)
$4.00 M(+7.7%)
Sept 2023
-
$3.71 M(-2.2%)
June 2023
-
$3.79 M(+37.3%)
Mar 2023
-
$2.76 M(+12.5%)
Dec 2022
$2.46 M(-50.1%)
$2.46 M(-37.8%)
Sept 2022
-
$3.95 M(-25.9%)
June 2022
-
$5.33 M(+12.3%)
Mar 2022
-
$4.75 M(-3.5%)
Dec 2021
$4.92 M(-19.7%)
$4.92 M(-4.3%)
Sept 2021
-
$5.14 M(+4.7%)
June 2021
-
$4.91 M(-34.4%)
Mar 2021
-
$7.48 M(+22.1%)
Dec 2020
$6.13 M(-21.6%)
$6.13 M(-2.9%)
Sept 2020
-
$6.31 M(-48.4%)
June 2020
-
$12.23 M(+76.3%)
Mar 2020
-
$6.94 M(-11.2%)
Dec 2019
$7.82 M(-62.1%)
$7.82 M(-52.0%)
Sept 2019
-
$16.28 M(+4.8%)
June 2019
-
$15.54 M(-8.4%)
Mar 2019
-
$16.96 M(-17.8%)
Dec 2018
$20.63 M(+75.5%)
$20.63 M(+13.9%)
Sept 2018
-
$18.11 M(+19.3%)
June 2018
-
$15.18 M(-3.5%)
Mar 2018
-
$15.74 M(+33.8%)
Dec 2017
$11.76 M(-12.2%)
$11.76 M(-60.1%)
Sept 2017
-
$29.49 M(+16.2%)
June 2017
-
$25.38 M(+2.2%)
Mar 2017
-
$24.84 M(+85.5%)
Dec 2016
$13.39 M(+21.0%)
$13.39 M(-5.2%)
Sept 2016
-
$14.13 M(-6.2%)
June 2016
-
$15.05 M(+2.8%)
Mar 2016
-
$14.65 M(+32.3%)
Dec 2015
$11.07 M(+41.4%)
$11.07 M(+13.1%)
Sept 2015
-
$9.79 M(+0.2%)
June 2015
-
$9.77 M(+5.5%)
Mar 2015
-
$9.26 M(+18.2%)
Dec 2014
$7.83 M(-34.0%)
$7.83 M(-17.0%)
Sept 2014
-
$9.43 M(-13.2%)
June 2014
-
$10.86 M(-2.5%)
Mar 2014
-
$11.13 M(-6.1%)
Dec 2013
$11.86 M(+1.3%)
$11.86 M(+4.8%)
Sept 2013
-
$11.31 M(+9.3%)
June 2013
-
$10.35 M(-20.5%)
Mar 2013
-
$13.01 M(+11.2%)
Dec 2012
$11.70 M(+5.0%)
$11.70 M(-26.3%)
Sept 2012
-
$15.86 M(+25.8%)
June 2012
-
$12.61 M(-13.6%)
Mar 2012
-
$14.60 M(+31.0%)
Dec 2011
$11.15 M(+47.1%)
$11.15 M(-14.7%)
Sept 2011
-
$13.06 M(-13.3%)
June 2011
-
$15.07 M(+9.0%)
Mar 2011
-
$13.82 M(+82.5%)
Dec 2010
$7.58 M(-60.1%)
$7.58 M(-8.0%)
Sept 2010
-
$8.23 M(-11.8%)
June 2010
-
$9.33 M(-40.5%)
Mar 2010
-
$15.70 M(-17.3%)
DateAnnualQuarterly
Dec 2009
$18.99 M(+92.5%)
$18.99 M(+12.1%)
Sept 2009
-
$16.94 M(-3.5%)
June 2009
-
$17.55 M(+98.5%)
Mar 2009
-
$8.84 M(-10.4%)
Dec 2008
$9.87 M(-5.8%)
$9.87 M(-12.4%)
Sept 2008
-
$11.27 M(+2.8%)
June 2008
-
$10.96 M(+17.4%)
Mar 2008
-
$9.33 M(-10.9%)
Dec 2007
$10.47 M(+31.4%)
$10.47 M(+16.8%)
Sept 2007
-
$8.96 M(+12.9%)
June 2007
-
$7.94 M(+12.0%)
Mar 2007
-
$7.09 M(-11.0%)
Dec 2006
$7.97 M(-54.7%)
$7.97 M(-53.9%)
Sept 2006
-
$17.29 M(-1.7%)
June 2006
-
$17.59 M(-4.1%)
Mar 2006
-
$18.33 M(+4.1%)
Dec 2005
$17.61 M(+99.6%)
$17.61 M(+123.5%)
Sept 2005
-
$7.88 M(+2.4%)
June 2005
-
$7.70 M(+8.6%)
Mar 2005
-
$7.09 M(-19.6%)
Dec 2004
$8.82 M(+25.5%)
$8.82 M(-16.3%)
Sept 2004
-
$10.54 M(+5.2%)
June 2004
-
$10.02 M(+24.1%)
Mar 2004
-
$8.07 M(+14.9%)
Dec 2003
$7.03 M(+119.5%)
$7.03 M(+77.9%)
Sept 2003
-
$3.95 M(+35.0%)
June 2003
-
$2.92 M(+4.3%)
Mar 2003
-
$2.81 M(-12.4%)
Dec 2002
$3.20 M(+78.5%)
$3.20 M(+51.5%)
Sept 2002
-
$2.11 M(+23.2%)
June 2002
-
$1.72 M(+12.9%)
Mar 2002
-
$1.52 M(-15.3%)
Dec 2001
$1.79 M(-25.2%)
$1.79 M(+110.1%)
Sept 2001
-
$854.00 K(-21.7%)
June 2001
-
$1.09 M(-36.1%)
Mar 2001
-
$1.71 M(-28.8%)
Dec 2000
$2.40 M(+62.5%)
$2.40 M(+18.1%)
Sept 2000
-
$2.03 M(+17.5%)
June 2000
-
$1.73 M(-0.9%)
Mar 2000
-
$1.75 M(+18.2%)
Dec 1999
$1.48 M(+34.2%)
$1.48 M(+195.2%)
Sept 1999
-
$500.00 K(-54.5%)
June 1999
-
$1.10 M(-15.4%)
Mar 1999
-
$1.30 M(+18.2%)
Dec 1998
$1.10 M(+83.3%)
$1.10 M(+22.2%)
Sept 1998
-
$900.00 K(0.0%)
June 1998
-
$900.00 K(+12.5%)
Mar 1998
-
$800.00 K(+33.3%)
Dec 1997
$600.00 K(+100.0%)
$600.00 K(-60.0%)
Sept 1997
-
$1.50 M(+15.4%)
June 1997
-
$1.30 M(+225.0%)
Mar 1997
-
$400.00 K(+33.3%)
Dec 1996
$300.00 K(0.0%)
$300.00 K(0.0%)
Sept 1996
-
$300.00 K(0.0%)
June 1996
-
$300.00 K(-25.0%)
Mar 1996
-
$400.00 K(+33.3%)
Dec 1995
$300.00 K
$300.00 K(-87.0%)
June 1995
-
$2.30 M(+15.0%)
Mar 1995
-
$2.00 M

FAQ

  • What is Windtree Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Windtree Therapeutics?
  • What is Windtree Therapeutics annual current liabilities year-on-year change?
  • What is Windtree Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Windtree Therapeutics?
  • What is Windtree Therapeutics quarterly current liabilities year-on-year change?

What is Windtree Therapeutics annual total current liabilities?

The current annual current liabilities of WINT is $4.00 M

What is the all time high annual current liabilities for Windtree Therapeutics?

Windtree Therapeutics all-time high annual total current liabilities is $20.63 M

What is Windtree Therapeutics annual current liabilities year-on-year change?

Over the past year, WINT annual total current liabilities has changed by +$1.54 M (+62.64%)

What is Windtree Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of WINT is $8.78 M

What is the all time high quarterly current liabilities for Windtree Therapeutics?

Windtree Therapeutics all-time high quarterly total current liabilities is $29.49 M

What is Windtree Therapeutics quarterly current liabilities year-on-year change?

Over the past year, WINT quarterly total current liabilities has changed by +$5.07 M (+136.59%)